Photo from archive.org
Exogenous human herpes virus 6 (HHV-6) reinfection has never been reported in patients receiving tumor-infiltrating T lymphocytes therapy. We report an unusual case of HHV-6 infection following infusion of HHV-6… Click to show full abstract
Exogenous human herpes virus 6 (HHV-6) reinfection has never been reported in patients receiving tumor-infiltrating T lymphocytes therapy. We report an unusual case of HHV-6 infection following infusion of HHV-6 infected autologous T lymphocytes. HHV-6 infection could interfere with the tumor antigen immune recognition and the efficacy of immunotherapy.
Keywords:
exogenous human;
herpesvirus reinfection;
human herpesvirus;
tumor infiltrating;
tumor
Journal Title: Cytotherapy
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cytotherapy
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!